Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction Chemotherapy in GDF15-High OSCC
NCT02285530Phase 2Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in oral squamous cell carcinoma (OSCC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Dec 2019; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT02285530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285530.